Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5566 AL 5580

Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans

Deguil J, Ravasi L, Auffret A, Babiloni C, Bartres Faz D, Bragulat V, Cassé-Perrot C, Colavito V, Herrero Ezquerro MT, Lamberty Y, Lanteaume L, Pemberton D, Pifferi F, Richardson JC, Schenker E, Blin O, Tarragon E, Bordet R.

Drug Discov Today Technol. 2013 Sep;10(3):e329-42. doi: 10.1016/j.ddtec.2013.03.003.

The oxidative stress hypothesis in Alzheimer's disease

Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R.

Psychiatr Danub. 2013 Dec;25(4):401-9.

Neuroimaging and the search for a cure for Alzheimer disease

Petrella JR.

Radiology. 2013 Dec;269(3):671-91. doi: 10.1148/radiol.13122503.

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020

Hampel H, Lista S, Teipel SJ, Garaci F, Nisticò R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardjian H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehéricy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B.

Biochem Pharmacol. 2014 Apr 15;88(4):426-49. doi: 10.1016/j.bcp.2013.11.009. Epub 2013 Nov 22.

[Oxidative stress hypothesis for Alzheimer's disease and its potential therapeutic implications]

Nunomura A.

Rinsho Shinkeigaku. 2013;53(11):1043-5. doi: 10.5692/clinicalneurol.53.1043.

Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties

Papadopoulos V, Lecanu L.

J Neuroendocrinol. 2012 Jan;24(1):93-101. doi: 10.1111/j.1365-2826.2011.02167.x.

Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease

Haas C.

J Alzheimers Dis. 2012;28(2):241-81. doi: 10.3233/JAD-2011-110986.

Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins

Schneider A, Simons M.

J Neurochem. 2012 Jan;120(1):1-3. doi: 10.1111/j.1471-4159.2011.07548.x.

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs

Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F.

Br J Clin Pharmacol. 2012 Apr;73(4):504-17. doi: 10.1111/j.1365-2125.2011.04134.x.

Tau-targeted treatment strategies in Alzheimer's disease

Götz J, Ittner A, Ittner LM.

Br J Pharmacol. 2012 Mar;165(5):1246-59. doi: 10.1111/j.1476-5381.2011.01713.x.

Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease

Uenaka K, Nakano M, Willis BA, Friedrich S, Ferguson-Sells L, Dean RA, Ieiri I, Siemers ER.

Clin Neuropharmacol. 2012 Jan-Feb;35(1):25-9. doi: 10.1097/WNF.0b013e31823a13d3.

Reviewing the role of donepezil in the treatment of Alzheimer's disease

Doody RS, Cummings JL, Farlow MR.

Curr Alzheimer Res. 2012 Sep;9(7):773-81. doi: 10.2174/156720512802455412.

Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease

Tobinick E.

Curr Alzheimer Res. 2012 Jan;9(1):99-109. doi: 10.2174/156720512799015073.

Health state values for use in the economic evaluation of treatments for Alzheimer's disease

Shearer J, Green C, Ritchie CW, Zajicek JP.

Drugs Aging. 2012 Jan 1;29(1):31-43. doi: 10.2165/11597380-000000000-00000.

Natural antioxidants in prevention and management of Alzheimer's disease

Zhao Y, Zhao B.

Front Biosci (Elite Ed). 2012 Jan 1;4(3):794-808. doi: 10.2741/419.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias